Pharmaceutical Executive-07-01-2020

Pharmaceutical Executive

Central Focus: Targeting Unmet Need in CNS

July 09, 2020

Features

40

7

Former physician and clinical researcher Antony Loebel, now president and CEO of Sunovion Pharmaceuticals, discusses his career-long mission to advance novel treatments for patients suffering from serious and underserved CNS disorders.

Will the Industry Rise to the Occasion?

July 09, 2020

From the Editor

40

7

Gilead's pricing of COVID drug remdesivir is a reminder of pharma's tenuous path forward as it seeks a more holistic image makeover.

Culture and Compliance: Building a Culture of Business Ethics

July 08, 2020

Features

40

7

Amid the limitations of traditional compliance programs that emphasize control measures, here are steps biopharma companies can implement in their own cultures to ensure they’re behaving and performing with integrity.

Fauci: Industry Will ‘Walk Away’ From COVID Price Controls

July 07, 2020

Columns

40

7

Stresses the need for fair pricing of therapies, while ensuring access.

Enterprise Leadership: Is Compliance Ripe for Disruption?

July 01, 2020

Features

40

7

Case study illustrates how compliance teams, in today’s climate, can foster innovation across an organization to help achieve corporate goals.

Pharmaceutical Executive, July 2020 Issue (PDF)

July 01, 2020

Issue PDF

40

7

Click the title above to open the Pharmaceutical Executive July 2020 issue in an interactive PDF format.